FDA Approves Second CAR-T Cancer Therapy to Treat Multiple Myeloma, Opening the Door for Greater Access

The Food and Drug Administration on Monday approved a new CAR-T therapy for multiple myeloma, a move that could ease strain on limited supplies of potentially lifesaving cancer therapies. Read more…